The panelists said that vaginal creams and other localized therapies for menopause are safe and vastly underused by women who could benefit.

On Nov. 26, 2019, ChemoCentryx issued a press release announcing that the Advocate trial met both of its primary endpoints, saying Tavneos showed noninferiority of disease remission at 26 weeks and ...

Members of an FDA expert panel discussed the risks and benefits of selective serotonin reuptake inhibitors, or SSRIs, for ...

An FDA-cleared predictive analytic tool for hemodynamic instability may soon leverage its success in critical care to the ...

An agency-sponsored forum included critics of psychiatry who believe the drugs can harm a developing fetus. Other experts ...

The mental health industry watchdog Citizens Commission on Human Rights International (CCHR) is calling for sweeping reforms ...

Smoke was seen rising after strikes hit Deir al-Balah in the Gaza Strip on Sunday. It comes as the Israeli military published ...

Pharmaceutical companies spend $6 billion each year on direct-to-consumer ads, with every dollar spent netting more than $4 ...

Dexcom is recalling 19 models of its continuous glucose monitoring receivers due to a speaker malfunction that could prevent alerts for dangerous blood sugar levels. The affected devices are models ...

Trial evaluated number of supplemental injections needed for the treatment of DME for patients on ILUVIEN versus the ...

These innovations are revolutionizing pharmaceutical packaging by enhancing drug safety, combating counterfeiting, ensuring ...

A new study from Turkey has raised questions about the potential effects of the Pfizer-BioNTech COVID-19 vaccine on eye health, revealing changes in the cornea’s inner layer that may signal stress or ...